Prolonged survival of rat whole-limb allografts treated with cyclophosphamide, granulocyte colony-stimulation factor and FK506

Transplant International

Volumn 19, Issue 10, 2006, Pages 840-847

  Muramatsu, Keiichi ^a,b   You Xin, Song ^a   Hashimoto, Takahiro ^a   Matsunaga, Tsunemitsu ^a   Gondo, Toshikazu ^a   Taguchi, Toshihiko ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chimerism; Cyclophosphamide; Graft versus host disease; Granulocyte colony stimulation factor; Limb graft; Polymerase chain reaction

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL MIGRATION; CHIMERA; DOSE RESPONSE; DRUG EFFICACY; GRAFT SURVIVAL; LEUKOCYTE COUNT; MALE; MONOTHERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CYCLOPHOSPHAMIDE; EXTREMITIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENTS; LAC OPERON; MALE; RATS; RATS, INBRED LEW; TACROLIMUS; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33748513252     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00362.x     Document Type: Article

References (24)

1. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
2. Monaco AP. Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 2003; 75: 13.
3. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995; 60: 971.
4. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401.
5. Hewitt CW, Ramsamooj R, Patel MP, Yazdi B, Achauer BM, Black KS. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 1990; 50: 766.
6. Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation 2001; 72: 791.
7. Foster RD, Fan L, Neipp M et al. Donor-specific tolerance induction in composite tissue allografts. Am J Surg 1998; 176: 418.
8. Muramatsu K, Kurokawa Y, Ihara K, You-Xin S, Kawai S. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. J Surg Res 2005; 124: 38.
9. Muramatsu K, Bishop AT, Sunagawa T, Valenzuela RG. Fate of donor cells in vascularized bone grafts: identification of systemic chimerism by the polymerase chain reaction. Plast Reconstr Surg 2003; 111: 763.
10. Prabhune KA, Gorantla VS, Perez-Abadia G et al. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model. Transplantation 2003; 76: 1548.
11. Gorantla VS, Prabhune KA, Perez-Abadia G et al. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation 2003; 75: 922.
12. Takahashi M, Hakamata Y, Takeuchi K, Kobayashi E. Effects of different fixatives on beta-galactosidase activity. J Histochem Cytochem 2003; 51: 553.
13. Takahashi M, Hakamata Y, Murakami T et al. Establishment of lacZ-transgenic rats: a tool for regenerative research in myocardium. Biochem Biophys Res Commun 2003; 305: 904.
14. Muramatsu K, Doi K, Kawai S. Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin. J Hand Surg 1999; 24:586.
15. Tomita Y, Nomoto K. Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance. Immunobiology 1990; 181: 430.
16. Zhang QW, Mayumi H, Umesue M, Tomita Y, Nomoto K, Yasui H. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells. Transplantation 1997; 63: 1667.
17. Mayumi H, Umesue M, Nomoto K. Cyclophosphamide-induced immunological tolerance: an overview. Immunobiology 1996; 195: 129.
18. Okayama J, Ko S, Kanehiro H et al. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. J Surg Res 2004; 120: 102.
19. Iwai T, Tomita Y, Zhang QW, Shimizu I, Nomoto K, Yasui H. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Transpl Int 2005; 17: 795.
20. Ajiki T, Takahashi M, Inoue S et al. Generation of donor hematolymphoid cells after rat-limb composite grafting. Transplantation 2003; 75: 631.
21. Mathes DW, Randolph MA, Bourget JL et al. Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft. Transplantation 2002; 73: 1880.
22. Granger DK, Briedenbach WC, Pidwell DJ, Jones JW, Baxter-Lowe LA, Kaufman CL. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation 2002; 74: 1624.
23. Okabe T, Nomura H, Sato N, Ohsawa N. Large-scale preparation and characterization of human colony-stimulating factor. J Cell Physiol 1982; 110: 43.
24. Ramsamooj R, Llull R, Black KS, Hewitt CW. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 1999; 104: 1365.